2-26188148-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001168241.2(GAREM2):​c.2516G>T​(p.Ser839Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

GAREM2
NM_001168241.2 missense

Scores

2
10
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.38
Variant links:
Genes affected
GAREM2 (HGNC:27172): (GRB2 associated regulator of MAPK1 subtype 2)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GAREM2NM_001168241.2 linkuse as main transcriptc.2516G>T p.Ser839Ile missense_variant 6/6 ENST00000401533.7 NP_001161713.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GAREM2ENST00000401533.7 linkuse as main transcriptc.2516G>T p.Ser839Ile missense_variant 6/61 NM_001168241.2 ENSP00000384593 P1Q75VX8-1
GAREM2ENST00000407684.1 linkuse as main transcriptc.1886G>T p.Ser629Ile missense_variant 6/62 ENSP00000384581 Q75VX8-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 20, 2021The c.2516G>T (p.S839I) alteration is located in exon 6 (coding exon 6) of the GAREM2 gene. This alteration results from a G to T substitution at nucleotide position 2516, causing the serine (S) at amino acid position 839 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Uncertain
0.036
T
BayesDel_noAF
Benign
-0.19
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;.
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Benign
0.034
D
MetaRNN
Uncertain
0.48
T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;N
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-4.6
D;D
REVEL
Benign
0.21
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
0.55
P;.
Vest4
0.60
MutPred
0.35
Gain of catalytic residue at L844 (P = 0.0438);.;
MVP
0.43
ClinPred
0.99
D
GERP RS
5.1
Varity_R
0.77
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.24
Position offset: 14

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-26411017; API